文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.

作者信息

Wang Meili, Zhao Xiulan, Zhu Dongwang, Liu Tieju, Liang Xiaohui, Liu Fang, Zhang Yanhui, Dong Xueyi, Sun Baocun

机构信息

Department of Pathology, Tianjin Medical University, Tianjin, 300070, China.

Department of Pathology, General Hospital of Tianjin Medical University, Tianjin, 300052, China.

出版信息

J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.


DOI:10.1186/s13046-017-0533-1
PMID:28449718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5408450/
Abstract

BACKGROUND: The incidence and mortality rates of hepatocellular carcinoma (HCC) have steadily increased in recent years. A hypoxic microenvironment is one of the most important characteristics of solid tumors which has been shown to promote tumor metastasis, epithelial-mesenchymal transition and angiogenesis. Epithelial-mesenchymal transition and vasculogenic mimicry have been regarded as crucial contributing factors to cancer progression. HIF-1α functions as a master transcriptional regulator in the adaptive response to hypoxia. Lysyl oxidases like 2 (LOXL2) is a member of the lysyl oxidase family, which main function is to catalyze the covalent cross-linkages of collagen and elastin in the extracellular matrix. Recent work has demonstrated that HIF-1α promotes the expression of LOXL2, which is believed to amplify tumor aggressiveness. LOXL2 has shown to promote metastasis and is correlated with poor prognosis in hepatocellular carcinoma. The purpose of our study is to explore the role of HIF-1α in progression and metastasis of hepatocellular carcinoma by promoting the expression of LOXL2 as well as the potential regulatory mechanism. METHODS: HIF-1α, LOXL2 expression and CD31/periodic acid-Schiff double staining in HCC patient samples were examined by immunohistochemical staining. shRNA plasmids against HIF-1α was used to determine whether LOXL2 been increased by HIF-1α. We monitored a series of rescue assays to demonstrate our hypothesis that LOXL2 is required and sufficient for HIF-1α induced EMT and VM formation, which mediates cellular transformation and takes effect in cellular invasion. Then we performed GeneChip® Human Transcriptome Array (HTA) 2.0 in HepG2 cells, HepG2 cells overexpressed LOXL2 and HepG2 cells treated with CoCl. RESULTS: In clinical HCC tissues, it confirmed a positive relationship between HIF-1α and LOXL2 protein. Importantly, HIF-1α and LOXL2 high expression and the presence of vasculogenic mimicry were correlated to poor prognosis. HIF-1α was found to induce EMT, HCC cell migration, invasion and VM formation by regulating LOXL2. The results of microarray assays were analyzed. CONCLUSION: HIF-1α plays an important role in the development of HCC by promoting HCC metastasis, EMT and VM through up-regulating LOXL2. This study highlights the potential therapeutic value of targeting LOXL2 for suppression of HCC metastasis and progression.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/d0cda15b9b3c/13046_2017_533_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/f9cbb18139c2/13046_2017_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/7138b1cd3bd7/13046_2017_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/7761a54e90ad/13046_2017_533_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/e9d2889359cb/13046_2017_533_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/74afb54269ce/13046_2017_533_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/d0cda15b9b3c/13046_2017_533_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/f9cbb18139c2/13046_2017_533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/7138b1cd3bd7/13046_2017_533_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/7761a54e90ad/13046_2017_533_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/e9d2889359cb/13046_2017_533_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/74afb54269ce/13046_2017_533_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642b/5408450/d0cda15b9b3c/13046_2017_533_Fig6_HTML.jpg

相似文献

[1]
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.

J Exp Clin Cancer Res. 2017-4-27

[2]
Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.

BMC Cancer. 2020-1-13

[3]
LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.

J Cell Mol Med. 2018-12-1

[4]
Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.

Int J Oncol. 2016-5

[5]
The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.

Int J Mol Sci. 2017-2-27

[6]
Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.

Oncogene. 2015-3-9

[7]
Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.

Oncotarget. 2016-7-12

[8]
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.

BMC Cancer. 2013-3-9

[9]
Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.

J Exp Clin Cancer Res. 2018-6-4

[10]
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.

Hepatology. 2014-10-2

引用本文的文献

[1]
Hypoxia-mediated HES4 promotes the proliferation and motility of hepatocellular carcinoma cell by enhancing COL4A2 transcription.

Discov Oncol. 2025-7-25

[2]
Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025.

Front Oncol. 2025-6-30

[3]
The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinoma.

Cell Death Differ. 2025-7-5

[4]
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity.

Cancer Biol Med. 2025-6-19

[5]
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.

J Exp Clin Cancer Res. 2025-5-22

[6]
Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology.

Discov Oncol. 2025-4-10

[7]
TRMT10A regulates tRNA-ArgCCT mG9 modification to generate tRNA-derived fragments influencing vasculogenic mimicry formation in glioblastoma.

Cell Death Dis. 2025-3-26

[8]
M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4.

Mol Biomed. 2025-3-18

[9]
Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma.

Cell Death Differ. 2025-2-26

[10]
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma.

Discov Oncol. 2025-2-5

本文引用的文献

[1]
Cancer Statistics, 2017.

CA Cancer J Clin. 2017-1-5

[2]
Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.

Oncotarget. 2016-7-5

[3]
Role of epithelial to mesenchymal transition in hepatocellular carcinoma.

J Hepatol. 2016-5-17

[4]
The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.

Biomed Pharmacother. 2016-3-21

[5]
Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.

Oncotarget. 2017-5-2

[6]
ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.

Clin Transl Oncol. 2016-8

[7]
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.

Oncotarget. 2015-12-8

[8]
Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.

Exp Mol Pathol. 2015-10

[9]
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Br J Cancer. 2015-6-9

[10]
Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.

Oncol Rep. 2015-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索